Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
470.60    0.60 (0.13%)
Bid:
469.80
Ask:
470.20
Spread: 0.40 (0.085%)
Market Cap: £2.43b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Buyback Programme 3rd Tranche

3 Feb 2025 07:00

RNS Number : 5563V
QinetiQ Group plc
03 February 2025
 

News release

QinetiQ Group plc

Commencement of Third Tranche of Buyback Programme

3 February 2025 - QinetiQ Group plc ("QinetiQ" or the "Group") confirms the completion by Numis Securities Limited ("Deutsche Numis") of the second tranche of its £100 million share buyback programme (the "Programme") announced on 16 January 2024. As announced on 14 November 2024, QinetiQ is extending the Programme by £50m to deliver increased shareholder returns.

QinetiQ has today entered into an agreement with Deutsche Numis to extend the Programme through the execution of a third tranche ("the Third Tranche) with a maximum aggregate value of up to £50 million. Under the Third Tranche, which is expected to complete by no later than 30 June 2025, Deutsche Numis will make trading decisions independently of QinetiQ in accordance with certain pre-set parameters. The Third Tranche will be effected under the authority granted by shareholders at QinetiQ's Annual General Meeting held on 18 July 2024, and the maximum remaining number of shares that may be repurchased under the Third Tranche pursuant to that authority is 42,778,600 Ordinary Shares.

Any purchases under the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with the Buyback Authority, Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse (Amendment) (EU Exit) Regulations 2019.

Any Ordinary Shares purchased pursuant to the Programme will be cancelled, and the number of Ordinary Shares in issue reduced accordingly.

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

Stephen Lamacraft, Group Interim Director Investor Relations: +44 (0) 7471 885817

Lindsay Walls, Group Communications Director (Media enquiries): +44 (0) 7793 427582

James Field, Company Secretary: +44 (0) 7841 662957

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDGGDDCGGDGUB
Date   Source Headline
1st Jul 202010:46 amRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSDisposal of Boldon James to HelpSystems
23rd Jun 202011:46 amRNSDirector/PDMR Shareholding
12th Jun 202010:48 amRNSAnnual Financial Report
10th Jun 202012:31 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSPreliminary Results
19th May 20204:05 pmRNSDirectorate Change
12th May 202011:22 amRNSDirector/PDMR Shareholding
1st May 202011:16 amRNSBlock listing Interim Review
30th Apr 20207:00 amRNSAppointment of Broker
29th Apr 20204:17 pmRNSHolding(s) in Company
15th Apr 202010:35 amRNSDirector/PDMR Shareholding
1st Apr 20209:33 amRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading and COVID-19 update
20th Mar 202010:21 amRNSDirector/PDMR Shareholding
18th Mar 20202:13 pmRNSHolding(s) in Company
10th Mar 202011:13 amRNSDirector/PDMR Shareholding
11th Feb 202010:53 amRNSDirector/PDMR Shareholding
10th Feb 202012:14 pmRNSDirector/PDMR Shareholding
6th Feb 20209:40 amRNSHolding(s) in Company
4th Feb 20207:00 amRNSThird Quarter Trading Update
13th Jan 202012:09 pmRNSDirector/PDMR Shareholding
20th Dec 20191:24 pmRNSQinetiQ completes acquisition of MTEQ
10th Dec 20199:48 amRNSDirector/PDMR Shareholding
9th Dec 20199:04 amRNSHolding(s) in Company
28th Nov 20199:25 amRNSHolding(s) in Company
14th Nov 20197:00 amRNSInterim Results
12th Nov 201911:59 amRNSDirector/PDMR Shareholding
1st Nov 20199:30 amRNSBlock listing Interim Review
10th Oct 201911:37 amRNSDirector/PDMR Shareholding
2nd Oct 20197:00 amRNSQinetiQ acquisition of MTEQ
10th Sep 201912:06 pmRNSDirector/PDMR Shareholding
2nd Sep 201910:38 amRNSDirector/PDMR Shareholding
16th Aug 20191:35 pmRNSHolding(s) in Company
12th Aug 201912:35 pmRNSDirector/PDMR Shareholding
24th Jul 201912:11 pmRNSResult of AGM
24th Jul 20197:00 amRNSFirst Quarter Trading Update
10th Jul 20193:52 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:05 pmRNSDirector/PDMR Shareholding
2nd Jul 20193:19 pmRNSDirector Declaration
1st Jul 20194:53 pmRNSDirector/PDMR Shareholding
12th Jun 201911:11 amRNSAnnual Financial Report
11th Jun 201911:19 amRNSDirector/PDMR Shareholding
29th May 201911:59 amRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSPreliminary Results
10th May 201910:47 amRNSDirector/PDMR Shareholding
1st May 20191:41 pmRNSBlock listing Interim Review
10th Apr 20193:29 pmRNSDirector/PDMR Shareholding
10th Apr 20197:00 amRNSQinetiQ completes pension scheme buy-in
5th Apr 20191:13 pmRNSQinetiQ secures £1.3bn LTPA amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.